- $24.00m
- $42.25m
- $37.16m
- 24
- 48
- 72
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 14.2 | 24.3 | 37.2 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 3.94 | 7.21 | 12.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.59 | 3.37 | 30.1 | 51.3 | 65.1 |
Operating Profit | -1.59 | -3.37 | -15.9 | -27 | -28 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.67 | -3.87 | -16.1 | -27 | -29 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.67 | -3.87 | -16 | -26.5 | -28.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.67 | -3.87 | -16 | -26.5 | -28.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.67 | -3.87 | -16 | -26.5 | -28.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.467 | -1.08 | -6.35 | -5.2 | -3.99 |
Dividends per Share |